Antibody builders

by Jared Sagoff
Argonne biologist Rosemarie Wilton works on ways to stabilize antibodies, which tend to degrade over time.

Antibodies are often the first line of defense against the body's invaders.  Built to recognize and attack foreign bacteria and viruses, antibody molecules are released by cells to do battle with microbial hostiles as part of the body's natural immune response.

Because are naturally so good at recognizing a host of different pathogens, Argonne biologist Rosemarie Wilton has spent much of her career working to better stabilize antibodies and prevent them from degrading over time.

In one possible scenario Wilton described, a soldier might want to use antibodies to detect any in the environment.  However, in the high temperatures of the field environment, antibodies tend to degrade. Wilton and her colleagues have developed several methods to prolong the of antibodies.

Wilton and her colleagues at Argonne's Center for Nanoscale Materials have also begun to explore combining antibodies with inorganic nanoparticles that can selectively attack and destroy cancer cells. 

In a third study—funded by the National Institutes of Health—Wilton and a collaborator at the University of Cincinnati are testing antibodies to prevent relapse in addicts.  "By using antibodies, we're able to prevent addicts from getting high even if they happen to relapse and use cocaine, which hopefully makes it easier for them to kick the habit in the future," Wilton said. "The antibody binds to the cocaine molecule and prevents it from acting in the brain."

The anti-cocaine antibody study is especially promising because that particular antibody has a relatively long half-life—about three weeks, Wilton said.

add to favorites email to friend print save as pdf

Related Stories

Study explores barriers to HIV vaccine response

Sep 20, 2013

Researchers at The Scripps Research Institute (TSRI) discovered that an antibody that binds and neutralizes HIV likely also targets the body's own "self" proteins. This finding could complicate the development of HIV vaccines ...

New artificial protein mimics a part of the HIV outer coat

Oct 22, 2013

A team of scientists at Duke Medicine and Memorial Sloan-Kettering Cancer Center has created an artificial protein coupled with a sugar molecule that mimics a key site on the outer coat of HIV where antibodies can bind to ...

The hitchhiker antigen: Cause for concern?

Oct 23, 2013

Since antibodies first attained prominence as research reagents in modern biological science labs, researchers have been perplexed as to why one production lot can differ significantly from the next, in terms of performance. ...

Recommended for you

Fresh hope for preventing pneumonia in the elderly

8 hours ago

There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older patients.

Rural microbes could boost city dwellers' health

22 hours ago

The greater prevalence of asthma, allergies and other chronic inflammatory disorders among people of lower socioeconomic status might be due in part to their reduced exposure to the microbes that thrive in rural environments, ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

210
1 / 5 (5) Nov 19, 2013
DO ya think Rob Ford, would like to give that anti-cocaine antibody a shot....now...after all? Yes, I know the horse has already left the barn, but, just seeing a grand opportunity to test a potential cure, a REALLY grand opportunity! Science could use the publicity and all.
word-